Respiratorius AB (publ) (XSAT:RESP)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.320
-0.110 (-4.53%)
At close: Aug 6, 2026

Respiratorius AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
1.74.340.861.3518.334.96
Revenue Growth
16890.73%402.11%-35.79%-92.65%269.56%-19.77%
Cost of Revenue
-4.320.380.76-4.09
Gross Profit
1.70.020.480.5918.330.87
Selling, General & Admin
-3.564.65.137.495.42
Depreciation & Amortization Expenses
3.493.413.393.293.032.53
Research & Development
----17.36-
Total Operating Expenses
3.496.9788.4227.887.95
Operating Income
-3.49-6.95-7.51-7.83-9.55-7.07
Other Non-Operating Income (Expense)
-0-0.050.01-0.09-
Total Non-Operating Income (Expense)
00-0.050.01-0.09-
Pretax Income
-4.95-6.95-7.57-7.83-9.64-7.47
Net Income
-4.95-6.95-7.57-7.83-9.64-7.47
Net Income to Common
-6.68-6.95-7.57-7.83-9.64-7.47
Net Income Growth
------
Shares Outstanding (Basic)
764322
Shares Outstanding (Diluted)
764322
Shares Change
58.12%47.81%37.21%36.67%14.56%18.79%
EPS (Basic)
-0.95-1.17-1.89-1.00-5.00-4.00
EPS (Diluted)
-0.95-1.17-1.89-1.00-5.00-4.00
EPS Growth
------
Free Cash Flow
--3.12-4.6-4.26-2.9-5.79
Free Cash Flow Growth
------
Free Cash Flow Per Share
--0.53-1.15-1.46-1.36-3.10
Gross Margin
-0.50%55.99%43.46%100.00%17.59%
Operating Margin
-205.23%-160.15%-868.80%-581.76%-52.11%-142.66%
Profit Margin
-291.15%-160.14%-874.97%-581.35%-52.60%-150.60%
FCF Margin
--71.78%-531.71%-316.26%-15.83%-116.85%
EBITDA
-3.49-3.54-4.12-4.55-6.52-4.54
EBITDA Margin
-205.23%-81.61%-476.32%-337.61%-35.59%-91.61%
EBIT
-3.49-6.95-7.51-7.83-9.55-7.07
EBIT Margin
-205.23%-160.15%-868.80%-581.76%-52.11%-142.66%